PCT/2002/1 : PCT Gazette, Weekly Issue No. 1, 2002 - WIPO

01/2002
48 PCT Gazette - Section I - Gazette du PCT 3 Jan/jan 2002
LTD., 540, NARUDA, ODAWARA-SHI,
Kanagawa 250-0862 (JP). ARITA, Masayo
[JP/JP]; c/o FOOD FUNCTIONALITY
RESEARCH INSTITUTE, MEIJI MILK
PRODUCTS CO., LTD., 540, NARUDA,
ODAWARA-SHI, Kanagawa 250-0862 (JP).
KUME, Akitomo [JP/JP]; c/o NUTRI-
TION SCIENCE INSTITUTE, MEIJI MILK
PRODUCTS CO., LTD., 540, NARUDA,
ODAWARA-SHI, Kanagawa 250-0862 (JP).
UCHIDA, Katsuyuki [JP/JP]; c/o FOOD
FUNCTIONALITY RESEARCH INSTI-
TUTE, MEIJI MILK PRODUCTS CO.,
LTD., 540, NARUDA, ODAWARA-SHI,
Kanagawa 250-0862 (JP). TSUNOO, Hajime
[JP/JP]; c/o FOOD FUNCTIONALITY
RESEARCH INSTITUTE, MEIJI MILK
PRODUCTS, CO., LTD., 540, NARUDA,
ODAWARA-SHI, Kanagawa 250-0862 (JP).
(74) ARUGA, Mitsuyuki et al. / etc.; KYODO
BLDG., 3-6, NIHONBASHININGYOCHO
1-CHOME, CHUO-KU, Tokyo 103-0013
(JP).
(81) AE AG AL AM AT AU AZ BA BB BG BR
BY BZ CA CH CN CR CU CZ DE DK DM
DZ EE ES FI GB GD GE GH GM HR HU
ID IL IN IS JP KE KG KP KR KZ LC LK
LR LS LT LU LV MA MD MG MK MN MW
MX MZ NO NZ PL PT RO RU SD SE SG SI
SK SL TJ TM TR TT TZ UA UG US UZ VN
YU ZA ZW.
(84) AP (GH GM KE LS MW MZ SD SL SZ TZ
UG ZW); EA (AM AZ BY KG KZ MD RU
TJ TM); EP (AT BE CH CY DE DK ES FI
FR GB GR IE IT LU MC NL PT SE TR); OA
(BF BJ CF CG CI CM GA GN GW ML MR
NE SN TD TG).
(51) 7 A61K 35/78, 31/12, 31/216, 7/00, 7/16,
7/08, A61P 43/00, 37/08, A23L 1/30
(11) WO 02/00239
(21) PCT/JP01/05553
(13) A1
(22) 28 Jun/juin 2001 (28.06.2001)
(25) ja (26) ja
(30) 2000-194825 28 Jun/juin 2000
(28.06.2000)
JP
(30) 2000-198733 30 Jun/juin 2000
(30.06.2000)
JP
(30) 2000-198734 30 Jun/juin 2000
(30.06.2000)
JP
(43) 3 Jan/jan 2002 (03.01.2002)
(54) ANTIALLERGIC AGENTS, DRUGS,
FOODS, DRINKS OR COSMETICS
CONTAINING THEM AND PROCESS
FOR PRODUCING THE SAME
AGENTS ANTI-ALLERGIQUES, ME-
DICAMENTS, ALIMENTS, BOIS-
SONS OU PRODUITS COSMETIQUES
CONTENANT CES AGENTS ET PRO-
CEDES PERMETTANT DE PRODUIRE
CEUX-CI
(71) KIKKOMAN CORPORATION [JP/JP];
250, Noda, Noda-shi, Chiba 278-8601 (JP).
(for all designated States except / pour tous
les États désignés sauf US)
(72, 75) YAMAMOTO, Taichi [JP/JP]; c/o
Kikkoman Corporation, 250, Noda, Noda-shi,
Chiba 278-8601 (JP). KANAMORI,
Tomoko [JP/JP]; c/o Kikkoman Corporation,
250, Noda, Noda-shi, Chiba 278-8601 (JP).
YAMAGUCHI, Fumio [JP/JP]; c/o Kikkoman
Corporation, 250, Noda, Noda-shi,
Chiba 278-8601 (JP). SAITO, Makoto
[JP/JP]; c/o Kikkoman Corporation, 250,
Noda, Noda-shi, Chiba 278-8601 (JP).
TSUJI, Ryohei [JP/JP]; c/o Noda Institute
For Scientific Research, 399, Noda,
Noda-shi, Chiba 278-0037 (JP). OBATA,
Akio [JP/JP]; c/o Kikkoman Corporation,
250, Noda, Noda-shi, Chiba 278-8601 (JP).
(74) TSUKUNI, Hajime; SVAX TS Buidling,
22-12, Toranomon 1-chome, Minato-ku,
Tokyo 105-0001 (JP).
(81) AE AG AL AU BA BB BG BR BZ CA CN
CO CR CU CZ DM DZ EC EE GD GE HR
HU ID IL IN IS KR LC LK LR LT LV MA
MG MK MN MX NO NZ PL RO SG SI SK
TT UA US UZ VN YU ZA.
(84) AP (GH GM KE LS MW MZ SD SL SZ TZ
UG ZW); EA (AM AZ BY KG KZ MD RU
TJ TM); EP (AT BE CH CY DE DK ES FI
FR GB GR IE IT LU MC NL PT SE TR); OA
(BF BJ CF CG CI CM GA GN GW ML MR
NE SN TD TG).
(51) 7 A61K 35/78, A61P 15/00
(11) WO 02/00240 (13) A2
(21) PCT/US01/41141
(22) 27 Jun/juin 2001 (27.06.2001)
(25) en (26) en
(30) 60/214,472 27 Jun/juin 2000 US
(27.06.2000)
(43) 3 Jan/jan 2002 (03.01.2002)
(54) COMPOSITIONS AND METHODS FOR
TREATING FEMALES SEXUAL RE-
SPONSE
COMPOSITIONS ET PROCEDES POUR
LE TRAITEMENT DE L’EXCITATION
SEXUELLE CHEZ LA FEMME
(63) US 60/214,472 (CIP)
27 Jun/juin 2000 (27.06.2000)
(71) QUALILIFE PHARMACEUTICALS
INC. [US/US]; 1854 Wallace School Road,
Charleston, SC 29407-4888 (US).
(for all designated States except / pour tous
les États désignés sauf US)
(72, 75) CROSBY, Martin, G. [US/US];
Charleston, SC (US). BENNETT, Robert,
M. [US/US]; Charleston, SC (US).
(74) ZELANO, Anthony, J. et al. / etc.; Millen,
White, Zelano & Branigan, P.C., Arlington
Courthouse Plaza 1, Suite 1400, 2200 Clarendon
Boulevard, Arlington, VA 22201 (US).
(81) AE AG AL AM AT AU AZ BA BB BG BR
BY BZ CA CH CN CO CR CU CZ DE DK
DM DZ EE ES FI GB GD GE GH GM HR
HU ID IL IN IS JP KE KG KP KR KZ LC
LK LR LS LT LU LV MA MD MG MK MN
MW MX MZ NO NZ PL PT RO RU SD SE
SG SI SK SL TJ TM TR TT TZ UA UG US
UZ VN YU ZA ZW.
(84) AP (GH GM KE LS MW MZ SD SL SZ TZ
UG ZW); EA (AM AZ BY KG KZ MD RU
TJ TM); EP (AT BE CH CY DE DK ES FI
FR GB GR IE IT LU MC NL PT SE TR); OA
(BF BJ CF CG CI CM GA GN GW ML MR
NE SN TD TG).
(51) 7 A61K 38/00
(11) WO 02/00241 (13) A2
(21) PCT/EP01/08096
(22) 22 Jun/juin 2001 (22.06.2001)
(25) en (26) en
(30) 60/214,790 28 Jun/juin 2000 US
(28.06.2000)
(43) 3 Jan/jan 2002 (03.01.2002)
(54) COMPOSITIONS AND METHODS FOR
REGULATING THE CELL CYCLE
COMPOSITIONS ET PROCEDES POUR
REGULER LE CYCLE CELLULAIRE
(71) AVENTIS PHARMA S.A. [FR/FR]; 20
Avenue Raymond Aron, F-92160 Antony
(FR). SAINT ELIZABETH’S MEDICAL
CENTER [US/US]; 736 Cambridge Street,
Boston, MA 02135-2997 (US).
(for all designated States except / pour tous
les États désignés sauf US)
(72, 75) BRANELLEC, Didier [FR/FR]; 5 rue
Hector Berlioz, F-77170 Brie-Comte-Robert
(FR). LAVENNE, Elisabeth [FR/FR]; 3 rue
d’Anjou, F-94240 L’Hay Les Roses (FR). LE
ROUX, Aude [FR/FR]; 13 Allée Chenard
et Walcker, F-94320 Thiais (FR). MAH-
FOUDI, Abderrahim [FR/FR]; 41 rue des
Bergers, F-94440 Marolles en Brie (FR).
PERLMAN, Harris [US/US]; 3450 N. Lake
Shore Drive, Apt. 706, Chicago, IL 60657
(US). WALSH, Kenneth [US/US]; 207 Judy
Farm Road, Carlisle, MA 0741 (US).
(74) BOUVET, Philippe; Aventis Pharma S.A.,
Direction Brevets, 20 Avenue Raymond Aron,
F-92165 Antony Cedex (FR).
(81) AE AG AL AM AT AU AZ BA BB BG BR
BY BZ CA CH CN CO CR CU CZ DE DK
DM DZ EC EE ES FI GB GD GE GH GM
HR HU ID IL IN IS JP KE KG KP KR KZ
LC LK LR LS LT LU LV MA MD MG MK
MN MW MX MZ NO NZ PL PT RO RU SD
SE SG SI SK SL TJ TM TR TT TZ UA UG
US UZ VN YU ZA ZW.
(84) AP (GH GM KE LS MW MZ SD SL SZ TZ
UG ZW); EA (AM AZ BY KG KZ MD RU
TJ TM); EP (AT BE CH CY DE DK ES FI
FR GB GR IE IT LU MC NL PT SE TR); OA
(BF BJ CF CG CI CM GA GN GW ML MR
NE SN TD TG).
(51) 7 A61K 38/00
(11) WO 02/00242
(21) PCT/US01/20240
(13) A2
(22) 26 Jun/juin 2001 (26.06.2001)
(25) en (26) en
(30) 60/214,202 26 Jun/juin 2000
(26.06.2000)
US
(43) 3 Jan/jan 2002 (03.01.2002)
(54) HUMAN PAPILLOMA VIRUS TREAT-
MENT
TRAITEMENT DES INFECTIONS PAR
LE PAPILLOMAVIRUS
(63) US 60/214,202 (CIP)
26 Jun/juin 2000 (26.06.2000)
(71) STESSGEN BIOTECHNOLOGIES
CORPORATION [CA/CA]; 350-4243
Glandford Avenue, Victoria, British Columbia
V8Z 4B9 (CA).
(for all designated States except / pour tous
les États désignés sauf US)
(72, 75) NEEFE, John [US/US]; 562 Berwan
Baptist Road, Devon, PA 19333 (US).
GOLDSTONE, Stephen [US/US]; 444
Central Park West Apt 14A, New York, NY
10025 (US). WINNETT, Mark [CA/US];
824 Cherry Street, Phoenixville, PA 19460